Companhia de Saneamento de Minas Gerais (CSMG3) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
11 Nov, 2026Executive summary
3Q26 net revenue excluding construction rose 9.8% to R$2.032bn; consolidated revenue increased 13.4% to R$2.398bn.
Adjusted EBITDA rose 14.0% to R$828.4m; adjusted net income fell 6.0% to R$339.2m, while statutory net income declined 7.0% to R$335.7m.
Management’s 100-day plan focuses on universalization, operating efficiency, regulatory engagement, process simplification and financing for the next investment cycle.
Financial highlights
Net revenue excluding construction reached R$2.032bn, up 9.8%, supported by the 6.56% tariff adjustment and higher measured water and sewage volumes.
Adjusted EBITDA margin expanded to 40.8% from 39.3%; adjusted EBITDA excludes R$5.1m of D&O insurance expense related to the share offering.
Net financial expense was R$104.7m versus R$31.9m in 3Q25; derivatives and foreign-exchange variation had a negative R$52.0m YoY effect.
Net operating cash generation was R$704m, down 1.1% YoY; 9M operating cash flow was R$1.686bn.
Outlook and guidance
Annual tariff adjustment results were expected by Dec. 23, 2026, with the new tariffs scheduled to take effect Jan. 22, 2027.
The 2026–2029 tariff cycle recognizes delivered investments annually; the current cycle’s X Factor is 2.74%.
2033 coverage goals are 99% for water and 90% for sewage; management is reviewing processes, contracts, operating indicators, capital structure and financing alternatives.
The Paraopeba reservoir system was at 71.1% capacity on Nov. 6, 2026; no municipality was under rationing.
Latest events from Companhia de Saneamento de Minas Gerais
- Net revenue up to 14.7%, EBITDA margin at 39%, leverage at 2.8%, and concession terms extended.CSMG3
Q2 2026 - Net income fell 14.1% as investments and leverage rose, despite revenue growth and concession renewal.CSMG3
Q1 2026 - Net income reached BRL 1.42B, EBITDA margin 39.8%, and CapEx hit BRL 2.9B in 2025.CSMG3
Q4 2025 - CapEx rose 26%, EBITDA margin held near 40%, and privatization and investments advanced.CSMG3
Q3 2025 - Revenue up, profit down; investments and leverage rise amid regulatory changes.CSMG3
Q2 2025 - Net revenue up 9.6%, adjusted net income up 9.3%, and EBITDA margin at 40.5%.CSMG3
Q3 2024 - Net income up 30.4% and EBITDA margin at 41.4%, with record investments and higher dividends.CSMG3
Q2 2024 - Net income up 21.9% and investments up 45.9% year-over-year, with record-low delinquency.CSMG3
Q1 2025 - Revenue up 6.8% to R$6.97B, EBITDA margin 39.7%, net income R$1.32B, record investments.CSMG3
Q4 2024